Daunorubicin has 1 known drug interaction based on U.S. FDA drug labeling data. Notable interactions include combinations with Gadobenate Dimeglumine. Patients taking Daunorubicin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 1
Moderate: 1

Moderate (1)

Daunorubicin + Gadobenate Dimeglumine— MultiHance may compete for MOAT transporter and prolong systemic exposure of daunorubicin.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.